The Association of Age and Frailty With Adverse Events for Bortezomib and Carfilzomib: A Population-Based Analysis. Am J Hematol 2026 Aug;101(8):2028-2032
Date
05/01/2026
Pubmed ID
42062824DOI
10.1002/ajh.70349Scopus ID
2-s2.0-105037653247 (requires institutional sign-in at Scopus site)
Author List
Lemieux M, Chunara F, Szabo A, Van Oekelen O, Chakraborty R, Godara A, Shaikh H, Strouse C, Mohan M, Mohyuddin GR
Author
Aniko Szabo PhD Professor in the Data Science Institute department at Medical College of Wisconsin